Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial And Up
0 Comments |
Share |
88 Views |
Problem? |
02/06/08
Linked From Medical News Today
:
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced that it has initiated a Phase 1 clinical trial with AZ-007 (Staccato(R) zaleplon). AZ-007 is an